CREATING CONFUSION!


anonymous

Guest
Ok, XR was approved in February and we delayed the launch until May, and now we are hearing that many plans consider XR to be a line extension and are not approving it for patients. Here is my plan to deal with this, I WILL NOT promote XR until the managed care situation is solved. I will ONLY PROMOTE BID Austedo! How do you guys plan to handle this in your territory? Inexcusable that they are asking us to promote a product with the managed care situation being what it is! They have had PLENTY of time to get this right! Neurocrine is foaming at the mouth enjoying every moment of our confusion!
 

Ok, XR was approved in February and we delayed the launch until May, and now we are hearing that many plans consider XR to be a line extension and are not approving it for patients. Here is my plan to deal with this, I WILL NOT promote XR until the managed care situation is solved. I will ONLY PROMOTE BID Austedo! How do you guys plan to handle this in your territory? Inexcusable that they are asking us to promote a product with the managed care situation being what it is! They have had PLENTY of time to get this right! Neurocrine is foaming at the mouth enjoying every moment of our confusion!

That doesn’t sound like Teva at all. I’m sure glad my manager hasn’t informed our team that if we don’t launch, successfully, some of us may be in for some trouble. *yawn* I’m here for Uzedy
 
HD is 12-14% of Austedo business. Ingrezza has continually lost market share each year for the last 3 yrs overall. It will only be a matter of time before ausedo passes ingrezza.

Matter of time? We passed Ingrezza market share in Q-3 of last year. Our net Austedo Vovume change continues to be positive positive over Ingrezza since the start of 2023. Now we are getting conversions with XR which will have even greater impact in a relatively slow moving VMAT2 market.
 
Matter of time? We passed Ingrezza market share in Q-3 of last year. Our net Austedo Vovume change continues to be positive positive over Ingrezza since the start of 2023. Now we are getting conversions with XR which will have even greater impact in a relatively slow moving VMAT2 market.

Q1 2023, Ingrezza net sales $400 million with a 34% YOY growth, Austedo $180 million, 10% YOY growth.

If Austedo volume is higher, our rebates to insurance must be astronomical!
 
Q1 2023, Ingrezza net sales $400 million with a 34% YOY growth, Austedo $180 million, 10% YOY growth.

If Austedo volume is higher, our rebates to insurance must be astronomical!

Teva pulled Austedo q1 sales into q4. Neurocrine does the opposite. They push because of how they operate with ltc pharmacies and certain institutions. Thank for trying to talk business. Also know this information can be found in the share holder reports. Tevas q1s are weak. Neurocrines is always weak in q3. Do your home work and understand the companies you are talking about
 
Teva pulled Austedo q1 sales into q4. Neurocrine does the opposite. They push because of how they operate with ltc pharmacies and certain institutions. Thank for trying to talk business. Also know this information can be found in the share holder reports. Tevas q1s are weak. Neurocrines is always weak in q3. Do your home work and understand the companies you are talking about
Yes typical Teva …. manipulating sales figures. Sick crooked company run by morons and grifters.
 
Teva pulled Austedo q1 sales into q4. Neurocrine does the opposite. They push because of how they operate with ltc pharmacies and certain institutions. Thank for trying to talk business. Also know this information can be found in the share holder reports. Tevas q1s are weak. Neurocrines is always weak in q3. Do your home work and understand the companies you are talking about

It's YOY you idiot. Maybe you try and do your homework. Clown.
 
It's YOY you idiot. Maybe you try and do your homework. Clown.

Reread my post kid. I'm not talking yoy. I'm talking shareholder and growth reporting. What investor looks at yoy when it comes to revenue unless they are long or playing shorts. I'm talking quarterly comparisons and how they report EPS and cash. What noob is looking at yoy? Are you a sales rep pretending to know business? Kid, go back to your community College and get your money back. Go to clown school. You are a natural.
 
Reread my post kid. I'm not talking yoy. I'm talking shareholder and growth reporting. What investor looks at yoy when it comes to revenue unless they are long or playing shorts. I'm talking quarterly comparisons and how they report EPS and cash. What noob is looking at yoy? Are you a sales rep pretending to know business? Kid, go back to your community College and get your money back. Go to clown school. You are a natural.

Says the guy who thinks Austedo is outselling Ingrezza. Nice comeback on the clown school line, said no one.
 
Hey ass wipes, I'm almost certain the post #8, where they were talking about market volume over Ingrezza was in their territory or region. I know for a fact that back in Q3 and Q4 of last year there were many territories around the country that overtook Ingrezza in VMAT2 market volume. Quit trying to make this more than it is with all your financial analysist mumbo jumbo. Some of us have made really good bank beating the competition quarter over quarter. The last few quarterly sales contests have paid out extremely well for top performers too.
 
Says the guy who thinks Austedo is outselling Ingrezza. Nice comeback on the clown school line, said no one.

They never said "outselling". They said austedo was closing the gap. Explaining how the numbers are reported. The person was speaking about how austedo is "gaining marketshare on ingrezzza". Are you reading people posts or making up conversation with yourself? Teva has medication for that. Were you fired from teva or something?
 
Take your foreign socialist self of this board you homophobic POS. Nobody wants to read your strange European comments that don't apply over here in America. Leave your "interfering and gobbing" of animal statements over in your home country where people actually know what those idiotic terms mean!
Spend more time at the teva glorihole my friend
 
Take your foreign socialist self of this board you homophobic POS. Nobody wants to read your strange European comments that don't apply over here in America. Leave your "interfering and gobbing" of animal statements over in your home country where people actually know what those idiotic terms mean!
glorihole! Get ahead!
I see what you did there!
 


Write your reply...